Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HRTX
#3019
Heron Therapeutics, Inc.
1.1
9
-0.83%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-0.83%
Mudança mensal
-14.39%
Mudança em 6 meses
-11.85%
Mudança anual
-39.90%
Fechamento anterior
1.2
0
Open
1.1
9
Bid
Ask
Low
1.1
9
High
1.1
9
Volume
58
Mercados
Ações
Cuidados de saúde
HRTX
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
91.4 M
102.14 M
119.26 M
150.33 M
152.33 M
188.54 M
—
Valuation ratios
Enterprise value
1.83 B
842 M
274.44 M
255.44 M
207.26 M
217.5 M
1.03 B
Price to earnings ratio
—
—
-1.46
-2.36
-17
-10.83
-165
Price to sales ratio
—
—
2.46
2.05
1.62
—
—
Price to cash flow ratio
—
—
1.8
4.44
10.35
7.85
43.64
Price to book ratio
—
—
19.49
7.68
6.93
16.32
23.56
Enterprise value to EBITDA ratio
279.79
239.48
15.14
16.78
3.78
—
—
Profitability ratios
Return on assets %
0.64
0.72
0.73
0.5
0.06
0.08
0.08
Return on equity %
0.96
2.84
13.41
3.25
0.4
1.41
1.21
Return on invested capital %
1 091.33
872.93
674.56
465.61
48.29
8.33
—
Gross margin %
59.15
46.7
49.04
48.75
73.21
73.31
293.19
Operating margin %
257.52
252.27
162.21
87.07
7.99
1.64
7.58
EBITDA margin %
7.38
4.07
16.83
11.98
37.96
46.87
148.46
Net margin %
256.52
255.58
169.03
87.02
9.41
13.04
52.44
Liquidity ratios
Quick ratio
2.66
2.9
1.83
1.84
1.7
1.51
5.58
Current ratio
3.07
3.58
2.49
2.37
2.29
2.48
8.25
Inventory turnover
1.08
1.02
1.07
1.35
0.81
0.57
0.61
Asset turnover
0.2
0.26
0.39
0.54
0.63
0.63
0.64
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.49
0.59
0.67
0.64
0.13
1.54
Long term debt to total equity ratio
—
1.92
11
4.4
4.45
2.28
15.2
Per share metrics
Operating cash flow per share
—
—
1.35
0.43
0.15
0.17
0.16
EBIT per share
—
—
0.14
0.09
0.34
0.42
0.31
EBITDA per share
—
—
0.17
0.11
0.36
0.44
0.33
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
0.78
0.58
0.39
0.28
1.13
Net current asset value per share
—
—
1.89
1.37
1.37
1.43
5.23
Tangible book value per share
—
—
0.12
0.25
0.22
0.08
0.44
Working capital per share
—
—
1.13
0.79
0.77
0.85
1.99
Book value per share
—
—
0.12
0.25
0.22
0.08
0.44
Notícias
Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript
Lucro da Heron Therapeuti veio abaixo das projeções; receita supera estimativas
Heron Therapeuti earnings missed, revenue topped estimates
Heron apresenta crescimento de 48% do ZYNRELEF no 4º tri de 2025
Heron Q4 2025 slides: acute care surge drives 48% ZYNRELEF growth
Ações da Heron Therapeutics disparam após forte crescimento de receita no Q4
Heron Therapeutics stock soars after strong Q4 revenue growth
APONVIE da Heron é destaque em novas diretrizes para náusea pós-operatória
Heron’s APONVIE featured in new postoperative nausea guidelines
Jefferies reduz preço-alvo das ações da Heron Therapeutics devido ao declínio da franquia oncológica
Jefferies lowers Heron Therapeutics stock price target on oncology franchise decline
Heron Therapeutics, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:HRTX) 2025-11-04